baber/WOPTO huggingface dataset:
Patent IE-32866-L (IE)
Title: Antibiotic complex
IPC: A61K35/74
Filed: 1969-06-06
Abstract: 1,219,709. The antibiotic axenomycine. SOC. FARMACEUTICI ITALIA. 6 June, 1969 [11 June, 1968], No. 28849/69. Heading C2A. The novel antibiotic axenomycine, also named F.I. 2604, is produced by cultivating Streptomyces lisandri n. sp., I.P.V 1951, I.M.R.U. 3935, I.M.I. 137178, or an axenomycine-producing strain thereof, under aerobic conditions in an aqueous medium containing assimilable sources of carbon and nitrogen and mineral salts, and isolating the axenomycine from the cultivated medium. The cultivation is preferably carried out at 23-37‹ C. and pH 6-9 for 60-160 hours. Axenomycine is a complex of two components, axenomycines A and B. The complex and its components are amorphous yellowish-white substances, soluble in methyl, ethyl and propyl alcohol, sparingly soluble in water, ethyl acetate, acetone and chloroform, and insoluble in benzene and petroleum ether. They reduce Fehling's solution and ammoniacal silver nitrate, give a positive reaction with tetrazole blue and a weakly positive Molisch reaction. They give negative reactions with ferric chloride, the aniline phthalate test for aldoses and the naphthoresorcinol test for ketoses. Axenomycine A has the following characteristics: elementary analysis, 61.74% C, 8.52% H, 28.87% O; molecular weight 1451.3; melting point 127-142‹ C. to give a transparent reddish gel; [α]23‹ D = + 10À5‹ (C = 0.9 in MeOH); Rf = 0.49 on silica gel at pH 7.0 using n. butanol: acetic acid: water = 4: 0.5: 1; U.V. spectrum in MeOH has absorption peaks at 249, 254 and 330 mÁ and a shoulder at 265-268 mÁ; I.R. spectrum in a KBr disc has peaks at 2.94, 3À44, 5.78, 6.00, 6.16, 6.24, 6.88, 7.25, 7.41, 8.61, 8.85, 9.35, 10.00, 10.40, 10.95, 11.8 and 12À5 Á. Axenomycine B has the characteristics: elementary analysis, 62.8% C., 8.58% H, 27.8% O; molecular weight 1330.2; melting point 122- 140‹ C.; [α]23‹ D = + 5‹ (C = 0.9 in MeOH); Rf = 0À61 on silica gel at pH 7À0 using n. butanol: acetic acid: water = 4À0 : 0À5: 1; U.V. spectrum in MeOH has absorption peaks at 249, 254 and 330 mÁ and a shoulder at 265- 268 mÁ; I.R. spectrum in a KBr disc has peaks at 2.94, 3À40, 5.82, 6.00, 6.16, 6.24, 6.86, 7.25, 7.41, 8.60, 8.85, 9.35, 10.00, 10.40, 10.98, 11.8, and 12À5 Á. The antibiotic complex may be extracted from the separated mycelium with e.g. methanol, or from the whole broth with a water-immiscible solvent, and purified by precipitation with a non-solvent followed by counter-current distribution. The two components may be separated by chromatography on a silica gel column at pH 7.0, developing with BuOH: HAc: H 2 O, 4: 0À5: 1 by volume. The antibiotics have anthelmintic, antiprotozoal and antifungal activity. Pharmaceutical compositions comprise axenomycine complex or one of its components A or B together with a pharmaceutically acceptable vehicle.
Patent IE-800821-L (IE)
Title: Drainage component
IPC: E03F5/04
Filed: 1980-04-23
Abstract: A building or drainage component, such as for example a plastics gulley trap or an access chamber, has a part (5) which is easily divisable, e.g. along groove (9), into upper and lower sections (6, 7), each section then functioning as a socket to receive alternate ends of a length of pipe (10, Fig. 3 not shown), by means of which the two sections can be reconnected in spaced apart relationship to extend the height of the component. The extension pipe is located between a shoulder (11) and pegs (15) and may be cemented in position. <IMAGE>
[GB2075563A]
Patent FI-813268-L (FI)
Inventor: GOMEZ DANIEL
IPC: D21H17/69
Filed: 1981-10-19
Abstract: 1. Process for the preparation, by papermaking techniques, of a material in sheet form comprising fibres, a non-binding inorganic filler, a conventional organic papermaking binder and a flocculant, intended to improve the retention of the inorganic filler in the sheet, the formation of the sheet and its physical properties, characterised in that a homogeneous bath comprising the inorganic filler and the organic binder in prepared and this, before being introduced into the fibre suspension, is destabilised by means of a cationic flocculant chosen from among aqueous solutions of polyethyleneimine, polyamideamide crosslinked polyalkylamide, modified polyacrylamides, aluminium polychloride and cationic starches, as well as aqueous solutions of quaternary ammonium compounds such as hydroxypropyltrimethylammonium chloride.
Patent FI-822294-L (FI)
Inventor: WEBER GEORGE A
IPC: A01N25/04
Filed: 1982-06-28
Abstract: A microbiocidal composition in the form of a stable, pumpable aqueous dispersion contains methylene bis(thiocyanate) dispersed in an aqueous composition containing from 0.75 to 3.0% by weight of a copolyampholyte, in the form of a self-inverting emulsion, comprising polymer units resulting from dimethyldiallylammonium X theta , diethyldiallylammonium X theta , acrylamide and optionally acrylate; and from 50 to 15.0% by weight of a suspension-improving and viscosiry-improving inorganic substance in the form of colloidally fine particles. The composition is used as a microbiocide primarily in paper mills and cooling towers to inhibit the growth of slime-forming bacteria anci fungi usually encountered in pulp and paper mill systems, but can be used more generally for treating water contaminated with microbes.
Patent FI-854029-L (FI)
Inventor: HEFNER ROBERT E JR
IPC: C08G59/50
Filed: 1985-10-16
Abstract: When hardened these resins possess a higher heat- distortion point and/or a higher elongation point than epoxy resins developed without containing triazin groups or both triazin and oxazolin groups.
Patent IE-831149-L (IE)
Title: Brain-specific drug delivery
IPC: C07D499/68
Filed: 1983-05-17
Abstract: Dihydropyridine deriv.-drug cpds. of formula D'-DHC (I) and their salts are new, (D' is a centrally or testicularly acting drug species; and DHC is the reduced bio-oxidisable blood-brain barrier penetrating lipoidal form of a dihydropyridine in equilibrium with a pyridinium salt redox carrier. Provided that when DHC is 1-R-1,4-dihydro-3-pyridinylcarbonyl (R is lower alkyl or benzyl) and D' is a drug species contg. a single NH2 or OH gp. (as a p- or s-OH) linked directly through the NH2 or OH to the carbonyl function of DHC, then D' is not a sympathetic stimulant, steroid sex hormone, memory enhancer, long chain alkanol or anticancer or antitumour agent). (I) give site specific and sustained delivery of the centrally acting drug to the brain. They readily and easily penetrate the blood-brain barrier so that increased concns. are present in the brain; oxidn. of the dihydropyridine carrier in vivo to an ionic pyridinium salt prevents its elimination from the brain, while elimination from the general circulatory system is accelerated. This action ensures prolonged brain-specific action, while any systemic toxic effects are decreased and central toxicity is reduced. Site specific and sustained delivery to the testes is also achieved, esp. with drugs that cannot themselves penetrate the blood-testis barrier; they are useful for male contraception, improving sexual function esp. in veterinary use, etc.
Patent IE-781212-L (IE)
Title: Pharmaceutical preparation
IPC: A61P31/22
Filed: 1978-06-16
Abstract: The invention relates to new pharmaceutical preparations for the topical treatment of infections caused by herpes viruses, especially those which have been caused by herpes virus hominis, for example of herpes genitalis and herpes dermatitis. The preparations contain as antiviral agent a synergistic combination of an acid sulphated polysaccharide or acid sulphated polymer, in particular heparin, and zinc ions, and may further contain polyoxyethylene sorbitan monolaurate and/or -monooleate. They are usual types of preparations for topical administration such as tinctures, solutions, creams, ointments and, especially, gels.[EP0000133A1]
Patent IE-35749-L (IE)
Title: Chain cable.
IPC: B63B21/20
Filed: 1971-10-19
Abstract: 1372354 Chains P BRUCE 20 Jan 1972 [20 Oct 1970] 49665/70 Heading F2Q A chain comprises a plurality of links each of which includes a bar member 1 of U-shape and a cylindrical pin 2 attached integrally thereto and bridging the ends of the U-bar member, the diameter of the pin 2 being substantially equal to the gap between the ends of the U-bar member. The pin may be formed of a hollow cylindrical member.
[GB1372354A]
Patent IE-38670-L (IE)
Title: Non-stinging wound dressing
IPC: A61K9/70
Filed: 1973-12-21
Abstract: 1422459 Film-forming wound dressing NOVITAS NUPROT SA 21 Dec 1973 [27 Dec 1972] 59291/73 Headings A5B and A5R [Also in Division C4] A non-stinging wound dressing comprises (a) a film-forming plastic material dissolved in (b) a volatile solvent comprising a solvent which would sting the wound and sufficient 1, 1, 2, 2-tetrachloro-1, 2-difluoroethane to render the dressing non-stinging. The composition may include other medicinal ingredients and an aerosol propellant. Plastic materials specified include: copoly (2-ethoxy ethyl methacrylate - methylmethacrylate), copoly (n-butyl acrylate - isobutyl acrylate), copoly (n-butyl acrylate-methyl acrylate). Stinging solvents specified include: ethanol, acetone, ethyl acetate, amyl acetate, methanol, methyl ethyl ketone, chloroform and trichloroethylene. Other ingredients specified include: medicaments 2, 4, 4'-trichloro-2'-hydroxy diphenyl ether, benzocaine, xylocaine, bacitracin, cortisone, chloramphenicol, sulphonilamide, griseofulvin, zinc undecylenate; aerosol propellants 1, 1, 2-trichloro-1, 2, 2-trifluoroethane, trifluorochloromethane, difluorochloromethane.
[GB1422459A]
Patent IE-40212-L (IE)
Title: Pipe connector and valve
IPC: F16L41/06
Filed: 1974-11-19
Abstract: A pipe connection means for connecting at least one transversely extending pipe to a longitudinally extending transport pipe in which a connection unit engaging the transport pipe is provided with a flow channel extending normal and leading to the transport pipe to which the transversely extending pipe is attached, the connection unit also having a guiding channel extending transversely relative to the transport pipe, with the transport pipe having a recess arranged in the guiding channel, and a longitudinally movable and rotatable valve body mounted in the guiding channel and provided with a transverse through flow hole, with the transverse flow hole, in a fixed end position of the valve body, being arranged in line with the recess in the transport pipe and the flow channel and at right angles to the recess and the flow channel to prevent communication between the transport pipe and the transversely extending pipe, but upon rotation of the valve body, the transverse flow hole co-acts with the recess and flow channel to provide an adjustable flow communication between the transport pipe and the transversely extending pipe.[US3983897A]
Patent IE-812703-L (IE)
Title: Latex
IPC: C08F257/02
Filed: 1981-11-18
Abstract: Interpolymer latex and process for the preparation thereof, in which the latexes are aqueous dispersions of particles having a diameter which is essentially between 0.1 and 1  mu m of an interpolymer comprising a copolymer A of butadiene, styrene and at least one ethylenic unsaturated carboxylic acid and a polymer B of bis(2-chloroethyl)vinylphosphonate which is at least partly grafted onto copolymer A. They can be used in particular as binders, more particularly in the paper coating industry and in the textile industry.
Patent IE-842784-L (IE)
Title: Anchor device.
IPC: B63B21/50
Filed: 1984-10-30
Abstract: Anchor device for use offshore or onshore comprising a plate (15) to bear on the bottom or ground surface, and a plurality of cylindrical elements (16) extending through the plate (15) into the bottom or ground layers and forming a tubular envelope.
[WO8501925A1]
Patent IE-853194-L (IE)
Title: Dog and horse interferons
IPC: C07K16/00
Filed: 1985-12-17
Abstract: Method for producing recombinant horse and dog interferons, as well as said interferons.
Patent IE-883311-L (IE)
Title: Dual chambered mixing and dispensing vial
IPC: B65D25/08
Filed: 1988-11-02
Abstract: A dual chambered vial is equiped with a dislodgeable stopper device (16) between the two chambers (9, 15), whereby components of a mixture may be maintained in separate chambers until comingling is desired. The stopper (16) is dislodged by means of a plunger (18) activated by depression of flexible walls (14) of one chamber.
Patent NO-782241-L (NO)
Title: Fremgangsmaate ved fremstilling av benzazepinderivater
Inventor: HOLDEN KENNETH GEORGE
IPC: C07D/
Filed: 1978-06-28
Abstract: Fremgangsmåte ved fremstilling av benzazepinderivater
Patent NO-812739-L (NO)
Title: Hydraulisk motor.
Inventor: KUVICEK FRANTISEK
IPC: F04C/
Filed: 1981-08-13
Abstract: Hydraulisk motor med roterende ytre hus (8) som er forsynt med radielle boringer (3) i hvilke boringer motorens arbeidsstempler (1, 7) kan bevege seg. Innvendig i huset er anbragt to tannhjul (9) som kan rotere om hver sin aksel anbragt diametralt motsatt hverandre i forhold til husets rotasjonsakse og paralelt med denne. Tannhjulene (9) er i inngrep med en innvendig for- tanning i huset (8) men ikke med hverandre. Stempel- bevegelsen fremkommer ved at stemplenes indre ender hviler mot tanntoppene på de innvendige tannhjul (9) under deres og husets (8) rotasjon.
Patent NO-832469-L (NO)
Inventor: BORELL CARL MICHAEL
IPC: B02C17/00
Filed: 1983-07-06
Abstract: The present invention relates to a method for comminuting a coarse lump mineral material in an autogenous primary grinding system, in which an ingoing material is divided into a coarse fraction and a fine fraction is determined by a crushing point determined by the point of intersection between two tangents drawn through two adjacent inflexion points on a size distribution graph obtained by screen analysis of a grinding mill charge of material obtained after an autogenous grinding process. The smallest particle size of the coarse fraction is greater than the particle sizes in the upper of said inflexion points, and the ratio between said fractions is determined on the basis of achieving a given charge quantity for a particular, selected set-point power value fo the mill in question, and determined with respect to a selected degree of grinding.The grinding efficiency of autogenous primary grinding mills is greatly improved by means of the invention (Figure 4).
Patent NO-840732-L (NO)
Inventor: BANHOLZER ROLF
IPC: C07D295/02
Filed: 1984-02-27
Abstract: The compound of the formula   <IMAGE>   and non-toxic, pharmacologically acceptable acid addition salts thereof. The compound as well as its salts are useful as analgesics.
Patent NO-844561-L (NO)
Title: Spesifikk bindingsproeve basert paa enzymkaskadeamplifikasjon
Inventor: BLAKE DIANE A
IPC: G01N33/535
Filed: 1984-11-15
Abstract: Foreliggende oppfinnelse tilveiebringer spesifike bindingsforsøksmetoder og reagenssystemer for den kvantitative eller kvalitative bestemmelsen av en analytt i et væskemedium basert på heterogene eller homogene fremgangsmåter. Oppfinnelsen gjelder spesielt bruken av spesifike bindingsforsøks-teknikker hvor merket er en deltager i eller en modulator av en enzymreaksjon, hvorved et første enzym virker på et første substrat for å produsere et andre enzym. Det andre enzymet kan anvendes for å katalysere en påvisbar respons eller kan virke på et andre substrat for å produsere et tredje enzym. Merket velges fra det første substratet eller en kofaktor eller modulator av det første enzymet. I en utførelsesform, er det første substratet et zymogen som når det påvirkes av det første enzymet, produserer et andre enzym. Når det endelige enzymproduktet anvendes for å katalysere produksjonen av en påvisbar res-spons som er proporsjonal med konsentrasjonen av analytten, oppnås en forsterkning som muliggjør en meget følsom bestemmelse.
Patent NO-851288-L (NO)
Inventor: NOE CHRISTIAN ROLAND
IPC: C07D407/12
Filed: 1985-03-29
Abstract: Enantiomerically pure mono acetal-protected diols of the formula <IMAGE>  I  wherein A, B, C and D are hydrogen or a methyl group in any combination, M and N are aliphatic or araliphatic hydrocarbons, m and n are the numbers 0, 1 or 2, whereby the total of m plus n must be the number 1 or 2, their preparation and use for the syntheses of the pheromones (1R-exo)-Brevicomin, (1S-exo)-Brevicomin, (1R-endo)-Brevicomin and (1S-endo)-Brevicomin.
Patent NO-864144-L (NO)
Inventor: VANMARCKE LUC ALBERT
IPC: C05C13/00
Filed: 1986-10-17
Abstract: The invention concerns a method of producing fertilizer granules containing urea and ammonium sulphate by granulating a mixture containing urea, ammonium sulphate and water, which is characterized in that the ammonium sulphate is completely dissolved in an aqueous urea solution with a urea concentration of 70-85% by weight, the resulting solution is thickened to a dry content of 92-97% by weight, with a crystallization retarder for the urea being added in any stage of the treatment, following which the thickened solution is granulated in a fluidized bed of urea and ammonium sulphate containing nuclei, as well as urea, ammonium sulphate and crystallization retarder containing granules.
Patent NO-864556-L (NO)
Inventor: BALSCHMIDT PER
IPC: A61K/
Filed: 1986-11-14
Abstract: PCT No. PCT/DK86/00023 Sec. 371 Date Jan. 28, 1987 Sec. 102(e) Date Jan. 28, 1987 PCT Filed Mar. 14, 1986 PCT Pub. No. WO86/05497 PCT Pub. Date Sep. 25, 1986.Insulin derivatives in which one or more of the four amino acid residues of positions A4, A17, B13 and B21 comprise an uncharged side chain and pharmaceutical preparations containing these insulin derivatives.
Patent NO-870938-L (NO)
Inventor: WETTERLIN KJELL INGVAR LEOPOLD
IPC: A61M13/00
Filed: 1987-03-06
Abstract: Device in a previously known powder inhalator intended for inhalation of an air flow which contains pharmacologically active compound in micronized form. The powder inhalator comprises a nozzle unit (2) with a nozzle aperture (2a) as well as a container unit (3) with a releasing or dosing unit (6) for delivering the active compound. The air flow generated by inhalation is at least partly aspirated through an air conduit (7) located in the container unit (3), which conduit extends from an air inlet (8), communicating with the environment, via said releasing or dosing unit (6), up to said nozzle unit (2). According to the invention, deflector devices are stationarily arranged in the container unit (3) and/or in the nozzle unit (2), said deflector devices, for example in the shape of a helical channel portion (13), being arranged to create a powerful deflecting movement for the purpose of disrupting said powder particles into the respirable particle size distribution (less than 5  mu m).
Patent NO-873645-L (NO)
Inventor: FRANCAISE BERNARD
IPC: F04D19/00
Filed: 1987-08-28
Abstract: A blower has a tubular air flow guiding sleeve. An electric motor is located coaxially within the sleeve in a casing connected to the sleeve by flow-straightening blades and a propeller is fixed to a rotary shaft of the motor and placed in front of the blades. A central unit comprises the tubular casing constituting a single casting with the blades and a part of said sleeve surrounding the propeller. A length of that part around the propeller is machined concentrically to an inner surface of said casing slidably receiving the stator of the motor. A PTFE ring may be located in a recess of the sleeve in radial alignment with the propeller blade tips.
Patent NO-881829-L (NO)
Inventor: GRIFFIOEN WILLEM
IPC: G02B6/46
Filed: 1988-04-26
Abstract: Apparatus for installing cables with a certain stiffness, more in particular glass fibre cables, into a duct (6, 24) of a channelization system, using the working of a compressed gas, which apparatus is adapted to exert pushing forces on a cable (26) being introduced in order to support the compressed gas working on the cable in the duct. The apparatus comprises cable advancing means and gas inserting means. The cable advancing means include a hollow, substantially rectilinear cable lead-through channel (3) with an entrance end (4) and an exit end (5), at least one pair of wheels (8, 10; 9, 11) mounted opposite to each other for moving on a cable (26) disposed between these wheels into the direction of the outlet end (21) of the duct (6), and a pneumatic motor (15) coupled to at least one of said wheels for providing a driving couple to it. At least one of the wheels is coupled to a pneumatic piston/cylinder combination (13, 14), in such a way that when compressed gas is supplied to the pneumatic cylinder (14), transverse forces will be exerted on the cable (26) disposed between the wheels (8, 10; 9, 11). The gas inserting means include a gas channel (7), which debouches into the cable lead-through channel (3) and which is adapted for inserting compressed gas into the lead-through channel (3) between the wheels and the exit end (5) of the lead-through channel (3). The motor (15) is capable of providing a driving couple, which is larger than the driving couple, which has to act on the cable (26) to compensate a pressure difference existing at the inlet end of the duct between the pressure inside and the pressure outside the cable lead-through channel (3) as a consequence of inserting the compressed gas via the gas channel (7) into the cable lead-through channel (3). The pushing forces are exerted by the wheels on the cable (26) as a consequence of the cooperative effect of the driving couple and the transverse forces. The gas channel (7), the pneumatic motor (15) and the piston/cylinder combination may be coupled to the same compressor. For use in a tandem arrangement the apparatus comprises further a coupling unit (18) to be coupled to an outlet end (21) of a preceding duct section (24), and which includes a mainly hollow housing (19), an outlet pipe (23) for diverting a flow of gas, which may leave the outlet end (21) of the duct section (24), and an outlet opening (22) through which a cable may be led into the direction of the entrance end (4) of the cable lead-through channel (3). Advantages: the exerted transverse forces are very acurately adjustable and substantially constant; the apparatus is non-destructive to the cable when cable introduction is slowing down or stagnates; in a tandem arrangement the apparatus needs hardly any human interference and is safe for the operating staff. <IMAGE>
Patent NO-892600-L (NO)
Inventor: MCKINLAY PETER ROBERT
IPC: G01N19/04
Filed: 1989-06-22
Abstract: Modified apparatus for testing the adhesive strength of the bond between the liner and medium in corrugated paperboard in which a clamp is used having a plate 24 abutting one liner and fingers or prongs 21 holding the medium and liner against the plate 24. The bond between the medium and the other liner is measured by applying a force to a strip bonded to the other liner and measuring the applied force which results in failure of the bond. The sample preparation required is simplified with this design which avoids the use of hooks penetrating the sample.
Patent NO-904135-L (NO)
Inventor: MCCARTHY JAMES RAY
IPC: A61P3/06
Filed: 1990-09-21
Abstract: The present invention relates to a group of compounds which are novel substituted alkyl piperidines and which are useful in the treatment of fungal infections through the inhibition of cholesterol synthesis in mammals.
Patent NO-930140-L (NO)
Inventor: GERBER JAN
IPC: A61B/
Filed: 1993-01-15
Abstract: PCT No. PCT/NL91/00129 Sec. 371 Date Jan. 13, 1993 Sec. 102(e) Date Jan. 13, 1993 PCT Filed Jul. 18, 1991 PCT Pub. No. WO92/01421 PCT Pub. Date Feb. 6, 1992.A diagnostic testing device for the skin, comprising at least one compartment (3) for the accommodation of a diagnostic aid, and adhesive strip (1) on which the compartment is accommodated, and a removable protective strip (4) which is stuck to the adhesive strip at the same side as the compartment. The protective strip is provided with an opening (7) at the position of each compartment.
Patent NO-932954-L (NO)
Inventor: COE JOTHAM W
IPC: A61K31/505
Filed: 1993-08-19
Abstract: 2,4-diaminoquinazoline derivatives as potentiators of chemotherapeutic agents in the treatment of cancer.